Altimmune, Lonza Expand AdCOVID Manufacturing Pact

URLhttps://www.contractpharma.com/content-microsite/c
SourceCONTRACT PHARMA
Date Published03/12/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Lonza
Parent companyLonza Group AG
Type of work Manufacturing
If manufacturing, is the company a contract manufacturer?Yes
Reshoring category:Foreign Direct Investment
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2021
Country(ies) from which reshored:Switzerland
City reshored to:Houston
State(s) reshored to:TX
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredAdCOVID single-dose intranasal Covid-19 vaccine
What domestic positive factors made reshoring more attractive?Lead time/Time to market, Skilled workforce availability/training, Under-utilized capacity, Other, Covid-19
Find Reshoring Articles